Introduction to Buprenorphine Prescribing in Primary Care (Integrating MOUD into Primary Care Service: Part 1)

Introduction to Buprenorphine Prescribing in Primary Care (Integrating MOUD into Primary Care Service: Part 1) is developed to support providers who are interested in treating buprenorphine and haven’t yet taken the waiver training.  

This didactic training is the first part of a mini-residency program, followed by an individual on-site observation with an experienced faculty preceptor. In-person observation sessions must be scheduled a minimum of 4 weeks in advance by contacting Caroline Drob, Program Assistant. Sessions are available on a first come, first serve basis.

Pre-requisites: Participants must have their waiver or be eligible to obtain their buprenorphine waiver. Those who have not yet applied for their waiver, may do so by completing the Notification of Intent (buprenorphine application).

On-site observation is limited to providers who practice within Philadelphia County

Registration: https://www.eventbrite.com/e/414744731657

Cost: None

Credit: CME

---

Presenters:

Lara Carson Weinstein, MD, MPH, DrPH

• Associate Professor of Family Medicine, Program Director, Addiction Medicine Fellowship Site, Sidney Kimmel Medical College & Medical Director, Pathways to Housing PA, Project HOME Health Services

Kara Cohen, CRNP

• Associate Site Director, Pathways to Housing

Maggie Lowenstein, MD, MPH, MPhil

• Assistant Professor, Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine & Mobile Addiction Treatment Physician, Prevention Point Philadelphia

Nicole O’Donnell

• Certified Recovery Specialist, Clinical Research Coordinator, University of Pennsylvania: Center for Addiction Medicine and Policy

Dana Higgins, MPH

• Epidemiology Manager, Division of Substance Use Prevention and Harm Reduction, Philadelphia Department of Public Health

Ashish Thakrar, MD

• Internal Medicine & Addiction Medicine, National Clincian Scholars Program, University of Pennsylvania

---

CME Program Code: 23257

Target Audience:  Physicians, Physician Assistants, and Certified Registered Nurse Practitioners who have obtained their Buprenorphine Waiver training.

Learning Objectives:  After attending this program, participants will be able to:

1. Describe considerations for treating patients who have opioid use disorder that are unique to primary care
2. Describe practical and clinical considerations for providing sublocade to patients
3. Define concepts of harm reduction and trauma informed care.
4. Review Philadelphia specific epidemiology and the rationale for treating patients for opioid use disorder in primary care.